# CellPly s.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellply-s-r-l

- Industry: Biotechnology
- Headquarters: Bologna, Italy
- Website: www.cellply.com
- Total disclosed funding: $2.8M
- Latest round: Seed (Mar 20, 2014)
- Investors on record: 3

## About

Based in Italy, CellPly s.r.l. specializes in advanced cellular analysis technology, providing innovative solutions for characterizing immune cells with high precision and automation to support research and development in cellular therapies. CellPly s.r.l., founded in 2013 by Massimo Bocchi and headquartered in Bologna, Italy, focuses on advanced cellular analysis technology. CellPly s.r.l. specializes in advanced cellular analysis technology, particularly through its core product, the VivaCyte platform, which enables comprehensive characterization of immune cells at a single-cell resolution. This fully automated platform supports sample preparation, image processing, and data analysis. The product serves a wide client base, including academic institutions and biopharmaceutical companies, primarily in Europe and North America, addressing the growing demand for cellular therapies and immunological research. The company reported an EBITDA of EUR -2,505,371.50, reflecting its ongoing investment in product development and market reach. CellPly plans to enhance its product development efforts and expand its business reach in the US, North America, and Europe. This funding will facilitate new product designs and support entry into these targeted markets. In May 2026, CellPly s.r.l. raised EUR 7.15 million in venture funding led by Fondazione ENEA Tech e Biomedical, with participation from CDP Venture Capital. The company will use the funding to expand its platform internationally, develop new automated testing systems for cell therapy quality control, and integrate automation and artificial intelligence into its analysis tools.

## Funding rounds

- Seed, Mar 20, 2014, $2.8M — META Group, Italian Angels for Growth, Indaco Venture Partners

## Investors

- META Group (https://capitalatlas.ai/funds/meta-group) — Seed
- Italian Angels for Growth (https://capitalatlas.ai/funds/italian-angels-for-growth) — Seed
- Indaco Venture Partners (https://capitalatlas.ai/funds/indaco-venture-partners) — Seed